Contact

location_on

66 avenue des Champs-Elysées
75008 PARIS
France

CATHERINE MULLER
EVP BD

About us

3Biotech is a consulting and support company for drug development projects. Our core business is CMC, and we support biotechs in all aspects of their development, right through to the end of phase 2 and transfer to phase 3. The company has been in existence for over 10 years, founded and run by OFB, who has a proven track record.

Business offer

To date, we have been involved in over 80 projects, 8 of which are in phase 1, 3 in phase 2 and 2 in phase 3. We support our customers right from the LEAD selection stage We work on all types of molecules: small molecules, antibodies, ADCs, Bi/ Tri specific, cell therapy, gene therapy, vaccines, .... In addition to our CMC activity, we are also regularly involved in the upstream and downstream stages of biotech capital raising.

Activities

    Categories

    • Service

    Therapeutic applications

    Expertises

    Directory of Antibodies, Recombinant proteins and others
    • Immunotherapy lead optimization
    • Engineering
    • ADC
    • Linkers
    • Payloads
    • Protein scaffolds
    • Fragments
    • Multi-, bispecific
    • Fc-fusion proteins
    • Indication Prioritization
    • Antibody humanization
    • Affinity maturation
    • Proof of concept
    • Pharmacology potency
    • Exploratory toxicology
    • in-vitro & ex-vivo models
    • in-vivo models
    • Cell expansion
    • Gas permeable bags
    • G-Rex bioreactors
    • Wave-mixed bioreactors
    • CMC
    • GLP compliance
    • GLP compliance
    • Master Cell Bank
    • Production
    • Cell Line development
    • Clone selection
    • Characterization
    • Storage
    • Analytical development
    • Cell Culture
    • Media composition
    • Bioreactor conditions
    • Gene modification / Transduction
    • Retroviral & lentiviral vectors
    • Cell expansion
    • Wave-mixed bioreactors
    • Stirred tank reactors
Français English